Therapeutic synergism between 5' amino 5' deoxy thymidine and 5 iodo 2' deoxy uridine in the treatment of herpes simplex virus infections in vitro
Fischer, P.H.; Lee, J.J.; Chen, M.S.; Lin, T.S.; Prusoff, W.H.
Nelson, J D And C Grassi (Ed ) Current Chemotherapy And Infectious Disease, Vol 1 And 2; Proceedings Of The 11th International Congress And The 19th Interscience Conference on Antimicrobial Agents And Chemotherapy, Boston, Mass , Usa, Oct 1-5, 1979 Xxi+774p (Vol 1); Ix+1023p (Vol 2 ) The American Society For Microbiology: Washington, D C , Usa Illus P1366-1368
1980
Accession: 029444485
PDF emailed within 1 workday: $29.90
Related References
Spadari, S.; Ciarrocchi, G.; Focher, F.; Verri, A.; Maga, G.; Arcamone, F.; Iafrate, E.; Manzini, S.; Garbesi, A.; Tondelli, L. 1995: 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies Molecular Pharmacology 47(6): 1231-1238Otto, M.J.; Prusoff, W.H. 1982: Induction of an interfering factor associated with herpes simplex virus type 1 from infected cells exposed to 5 iodo 5' amino 2' 5' dideoxy uridine or 5 iodo 2' deoxy uridine Abstracts of the Annual Meeting of the American Society for Microbiology 82: S44
Fischer, P.H.; Chen, M.S.; Prusoff, W.H. 1980: The incorporation of 5-iodo-5'-amino-2',5-dideoxyuridine and 5-iodo-2'-deoxyuridine into herpes simplex virus DNA. Relationship between antiviral activity and effects on DNA structure Biochimica et Biophysica Acta 606(2): 236-245
Wigdahl, B.L.; Parkhurst, J.R. 1978: Inhibition of mouse l fibroblast cell and herpes simplex virus replication by 5 tri fluoro methyl 2 deoxy uridine role of l cell and herpes simplex virus induced deoxy thymidine kinase Abstracts of the Annual Meeting of the American Society for Microbiology 78: 8
Wigdahl, B.L.; Parkhurst, J.R. 1977: Effect of 5 tri fluoromethyl 2 deoxy uridine on the induction of deoxy thymidine kinase by herpes simplex virus type 1 Abstracts of the Annual Meeting of the American Society for Microbiology 77: 342
Martenet, A-Catherine 1975: The Treatment of Experimental Deep Herpes Simplex Keratitis with Ethyl-Deoxy-Uridine and Iodo-Deoxy-Cytidine Ophthalmic Research 7(3): 170-180
Wigdahl, B.L.; Parkhurst, J.R. 1977: Inhibition of hep 2 cell and herpes simplex virus type i induced deoxy thymidine kinase by derivatives of 5 tri fluoromethyl 2 deoxy uridine Abstracts of the Annual Meeting of the American Society for Microbiology 77: 306
Maccallum, F.O. 1968: The effect of 5 iodo 2 deoxy uridine anti viral on herpes simplex virus infections in guinea pig skin di methyl sulfoxide pharm adjunct British Journal Of Experimental Pathology: 277-282
Miyamoto, H.; Matsumura, K.; Nunomura, H.; Mitsui, Y. 1969: The incorporation of 5 iodo 2 deoxy uridine into viral dna of herpes simplex virus Nippon Ganka Gakkai Zasshi 73(8): 1064-1071
Davis, W.B.; Oakes, J.E.; Taylor, J.A. 1978: Treatment of herpes simplex virus infections in mice with 5 ethyl 2 deoxy uridine Abstracts of the Annual Meeting of the American Society for Microbiology 78: 7
Maccallum, F.O. 1970: The effect of iodo deoxy uridine on herpes simplex virus encephalitis in animals and man Annals Of The New York Academy Of Sciences: 20-28
Yoshida, H.; Sakata, H.; Hiyama, N.; Kondo, H.; Iwamoto, T. 1982: Use of the immuno peroxidase technique for estimation of susceptibility of herpes simplex virus to 5 iodo 2' deoxy uridine Rinsho Ganka 36(6): 583-586
Matsumura, K.; Fujimoto, M.; Mitsui, Y. 1973: Micro auto radiographic studies on incorporation of 5 iodo 2 deoxy uridine into herpes simplex virus Japanese Journal of Ophthalmology 17(2): 125-132
Schinazi, R.F.; Peters, J.; Sokol, M.K.; Nahmias, A.J. 1983: Therapeutic activities of 1 2 fluoro 2 deoxy beta d arabinofuranosyl 5 iodo cytosine and 1 2 fluoro 2 deoxy beta d arabinofuranosyl 5 iodo thymine alone and in combination with acyclovir and vidarabine in mice infected intra cerebrally with herpes simplex virus Antimicrobial Agents and Chemotherapy 24(1): 95-103
Pavan-Langston, D.; Park, N.H.; De Clercq, E. 1984: In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection Antiviral Research 4(1-2): 53-61
Yamamoto, S.; Kabuta, H. 1973: Genetic studies on herpes simplex virus part 1 recombination between plaque morphology and 5 iodo 2 deoxy uridine resistance Kurume Medical Journal 20(2): 87-93
Mancini, W.R.; Otto, M.J.; Prusoff, W.H. 1982: Increased herpes simplex virus type 1 thymidine kinase in the presence of 5' amino 5 iodo 2' 5' dideoxy uridine or 5' amino 2' 5' dideoxy thymidine Abstracts of the Annual Meeting of the American Society for Microbiology 82: S43
Burnett, J.W.; Katz, S.L. 1963: A study of the use of 5-iodo-2'- deoxyuridine in cutaneous herpes simplex Journal of Investigative Dermatology 40: 7-8
Kaufman, H.E. 1962: Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 109: 251-252
Chu, C.K.; Reichman, U.; Watanabe, K.A.; Fox, J.J. 1977: Nucleosides part 109 2 deoxy psi iso cytidine 2 deoxy psi uridine and 2 deoxy 1 methyl psi uridine isosteres of deoxy cytidine deoxy uridine and thymidine Journal of Heterocyclic Chemistry 14(6): 1119-1121